Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting semaglutide for weight loss in the UK means obtaining a prescription following a clinical assessment — it is a Prescription-Only Medicine and cannot be legally supplied without one. The licensed product for weight management is Wegovy, and a prescriber (not an algorithm, not an automated questionnaire) decides whether it is suitable for you based on your full health picture. Here is a clear account of how that process works, which route makes sense for your situation, and what to watch for along the way.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for semaglutide have already heard that it is available on the NHS and are wondering why they cannot simply ask their GP. The short answer is that NHS access is real but narrow. Under NICE's appraisal of semaglutide (TA875), Wegovy is recommended only through specialist weight management services, for a maximum of two years, and only for adults with a BMI of 35 or above who also have at least one weight-related condition. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Waiting lists for those specialist services run to months or years in most areas, and the criteria exclude many people who are still genuinely affected by excess weight.
Private prescribing is the other path. A GPhC-registered online pharmacy with independent prescribers can assess you, issue a private prescription and dispense Wegovy from the licensed UK supply chain, typically within a day. The cost sits with you, and that is worth factoring in early — our semaglutide cost guide explains what private treatment typically involves financially.
Neither route is inherently superior; it depends on your eligibility, how long you are willing to wait and what ongoing clinical support matters to you.
A common misconception is that BMI alone unlocks a prescription. It does not. The licensed indication for Wegovy covers adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or prediabetes. But meeting those numbers is the floor, not the ceiling. A prescriber also considers your medical history, current medicines, any contraindications (such as a personal or family history of certain thyroid conditions), and whether your goals are realistic and safe to pursue with this treatment.
That assessment is the reason semaglutide cannot be sold freely. It is also the reason a thorough consultation protects you. On the step-by-step Wegovy access guide we go deeper into what a responsible clinical review covers, including how prescribers approach dose increases and transfer patients coming from another provider.
If you are not sure where you stand on eligibility, the NHS BMI calculator gives you your starting figure; bring that and a list of any current medicines to your consultation.
Assuming you go through a regulated private pharmacy, the sequence is straightforward. You complete a clinical questionnaire; a GPhC-registered independent prescriber reads your answers personally and either approves the prescription, asks follow-up questions or, where treatment is not appropriate, tells you clearly why. Photo-ID verification and live video weight confirmation happen before anything is dispensed.
Once approved, the medicine ships from the pharmacy's own MHRA-regulated dispensing operation, tracked, in plain unbranded packaging. The semaglutide overview covers what arrives, how to store it and what the first few weeks tend to feel like. Subsequent supplies are not automatic, a prescriber reviews the clinical picture again before each repeat, which is both a legal requirement and a meaningful safety check.
If you are already on treatment elsewhere and considering a switch, the guide to obtaining Wegovy through a regulated pharmacy explains what evidence transfers typically require. And if at any point you want to stop treatment rather than continue, stepping down from Wegovy is something to plan with your prescriber rather than do abruptly.
The MHRA has warned publicly and repeatedly about fake weight-loss pens sold online and through social media. Counterfeit pens seized in the UK have contained insulin rather than semaglutide, causing serious harm. The enforcement pattern is consistent: sellers offering these medicines without a prescription, prices far below anything a licensed pharmacy could offer, and no verifiable GPhC registration. Any seller offering Wegovy at a price that seems implausibly low, or without requiring a clinical assessment, is a serious red flag.
Checking a pharmacy's GPhC registration takes under a minute at the GPhC pharmacy register. You can also report a suspect seller directly via the MHRA's Yellow Card scheme. These steps are worth taking before handing over payment or health information to any provider you have not verified.
If you want to understand more about what the full treatment journey looks like (lifestyle changes, what to expect alongside the medicine, and how clinical oversight works in practice) the weight-loss treatment overview covers the broader picture. When you are ready to talk through your own situation, speak to our prescribers through a free consultation and get a clinical view on whether semaglutide is appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.